bluebird bio (BLUE) Misses Q3 EPS by 11c

bluebird bio (NASDAQ: BLUE) reported Q3 EPS of ($0.61), $0.11 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $6.2 million.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• Bassett Furniture Industries (BSET) Tops Q2 EPS by 1c, Misses on Revenue
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance